4-HO-MiPT (4-hydroxy-N-methyl-N-isopropyltryptamine), sold under the name miprocin, is a synthetic psychedelic tryptamine that occupies a distinctive niche in the 4-substituted tryptamine family. Structurally, it is psilocin with one of the two methyl groups swapped for a bulkier isopropyl group -- a single modification that shifts the experience in directions psilocin never quite goes. Where psilocybin mushrooms lean heavily into visual complexity and existential weight, miprocin is the tryptamine people reach for when they want something warmer, more tactile, more embodied. It is one of the few psychedelics that has built a genuine reputation for enhancing physical sensation to the point that discussions of its effects are inseparable from discussions of touch, texture, and the body.
Alexander Shulgin documented the parent compound MiPT (N-methyl-N-isopropyltryptamine) in TiHKAL (1997), and the 4-hydroxy variant followed as the logical next step in the structure-activity relationship work that defined late 20th century tryptamine pharmacology. Unlike 4-AcO-DMT or 4-HO-DET, miprocin is the active free phenol -- it does not require metabolic conversion to work, which means the molecule hitting your serotonin receptors is the molecule you swallowed. This directness may contribute to the rapid, clean onset that users consistently report. Oral doses typically range from 12-25 mg in the common range, with effects lasting 4-6 hours.
The compound has earned a loyal following in the research chemical community, particularly among users who value its combination of visual richness, emotional warmth, and pronounced body effects. Reddit discussions of miprocin return again and again to two themes: the extraordinary tactile enhancement -- skin-on-skin contact, warm water, soft fabrics all become almost overwhelmingly pleasurable -- and a headspace clear enough that meaningful introspection remains accessible even at moderate doses. This lucidity, the ability to think clearly while perceiving a visually transformed world, is what separates miprocin from heavier tryptamines that dissolve the thinker along with the thought.
The body load is the trade-off. Miprocin produces more physical tension, nausea, and vasoconstriction than most members of its family, and at higher doses the body high can cross from pleasurable into genuinely uncomfortable territory. This is the compound's central tension: it gives you the most vivid body of any tryptamine, and sometimes that body protests.
Safety at a Glance
High Risk- Test Before You Trust
- Threshold: 5 mg | Light: 5-10 mg | Common: 12-25 mg | Strong: 25-35 mg
- Toxicity: Acute Physical Toxicity No formal human toxicological studies of 4-HO-MiPT exist. Safety assessment relies on class m...
- Overdose risk: Can You Fatally Overdose on 4-HO-MiPT? Fatal overdose from miprocin's pharmacological action alon...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
oral
Duration
oral
Total: 4 hrs – 6 hrsHow It Feels
The first twenty minutes are deceptively quiet. A spreading warmth begins somewhere behind the sternum and radiates outward through the chest, into the shoulders, down the arms. It feels like slipping into a bath. There is a softening of the muscles you did not know were tense, a loosening in the jaw and around the eyes. The air in the room seems to thicken slightly, becoming warmer and more present. Then the skin starts to wake up. This is the first real signal that miprocin is different from other tryptamines -- before the visuals arrive, before the headspace shifts, the body begins reporting in with extraordinary detail.
By thirty to forty-five minutes, the sensory amplification is unmistakable. Fabric against skin becomes an event. The weight of a blanket, the texture of a wooden surface under your fingertips, the feeling of your own hair -- everything tactile becomes vivid and layered in a way that is genuinely difficult to convey to someone who has not experienced it. This is where miprocin's reputation comes from: the body high is not a side effect, it is the main act. Running your hands under warm water feels so good it can stop you in your tracks. Touch between people becomes almost electric -- not necessarily sexual, though that dimension is famously enhanced, but a kind of hyper-awareness of physical connection that makes a hand on your shoulder feel like an entire conversation.
The visuals build simultaneously but feel secondary to the somatic experience. Colors warm and deepen -- ambers, crimsons, forest greens dominate the palette in a way that feels distinctly autumnal. Surfaces ripple with flowing, organic geometry: Art Nouveau vines, Turkish carpet patterns, the kind of living ornamentation that seems to grow from the objects rather than being projected onto them. Closed-eye visuals are lush and immersive, filled with landscapes that pulse with a warm, amber light. Music deepens enormously, each chord resonating in the chest as much as the ears.
The peak arrives around ninety minutes and sustains for two to three hours. The headspace is contemplative but remarkably clear. Where psilocybin might dissolve your sense of self and leave you grasping for familiar cognitive handholds, miprocin keeps the thinker intact while transforming what the thinker perceives. You can reflect, you can have conversations, you can navigate your environment -- all while inhabiting a body that feels like it has been tuned to receive on frequencies it normally misses. Emotional warmth is pervasive: a deep gratitude and tenderness toward whoever and whatever is nearby. Some people cry. Some laugh until they cannot breathe. Both feel equally appropriate.
The descent stretches over two to three hours, the visuals dimming gradually while the bodily warmth lingers. Physical tiredness arrives gently toward the end, a pleasant heaviness rather than exhaustion. The afterglow is widely regarded as one of the best in the tryptamine family -- a quiet, glowing contentment that can persist well into the next day, like the emotional residue of being held by something larger than yourself.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(21)
- Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
- Changes in felt bodily form— Changes in felt bodily form is the experience of one's body feeling as though it has altered its phy...
- Changes in felt gravity— A distortion of one's proprioceptive sense of gravity in which the perceived direction of gravitatio...
- Excessive yawning— Involuntary, repeated yawning that occurs far more frequently than normal and often without the usua...
- Frequent urination— Increased urinary frequency beyond normal patterns, caused by diuretic effects or bladder irritation...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
- Increased salivation— Increased salivation (hypersalivation or sialorrhea) is the excessive production of saliva beyond wh...
- Insomnia— A persistent inability to fall asleep or maintain sleep despite physical tiredness, often characteri...
- Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Pain relief— A suppression of negative physical sensations such as aches and pains, ranging from dulled awareness...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
- Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
- Temperature regulation disruption— Impaired thermoregulation causing unpredictable fluctuations between feeling hot and cold, with risk...
- Watery eyes— Excessive tear production causing overflow tearing and blurred vision, commonly occurring during opi...
Cognitive & Perceptual Effects
Visual(19)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Brightness alteration— Perceived increase or decrease in environmental brightness beyond actual illumination levels, common...
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
- Depth perception distortions— Alterations in how the distance of objects within the visual field is perceived, causing layers of s...
- Diffraction— The experience of seeing rainbow-like spectrums of color and prismatic halos embedded within bright ...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Perspective distortions— Distortion of perceived depth, distance, and size of real objects, making things appear closer, furt...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
- Visual acuity enhancement— Vision becomes sharper and more defined than normal, as though a slightly blurry lens has been broug...
- Visual twisting— A visual distortion in which portions of the visual field appear to curl, spiral, or rotate around a...
Cognitive(26)
- Amnesia— A complete or partial inability to form new memories or recall existing ones during and after substa...
- Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
- Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
- Anxiety suppression— A partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental st...
- Autonomous voice communication— Autonomous voice communication is the experience of hearing and engaging in conversation with one or...
- Catharsis— A powerful emotional release and cleansing involving the surfacing, processing, and resolution of de...
- Cognitive euphoria— A cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Creativity enhancement— An increase in the ability to imagine new ideas, overcome creative blocks, think about existing conc...
- Deja vu— Intense, often prolonged sensation of having already experienced the current moment, common with psy...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Enhancement and suppression cycles— Enhancement and suppression cycles is a distinctive cognitive effect in which the mind alternates be...
- Feelings of impending doom— Feelings of impending doom is the sudden onset of an overwhelming, visceral certainty that something...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Increased sense of humor— A general amplification of one's sensitivity to finding things humorous and amusing, often causing p...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Personal bias suppression— A decrease in the personal, cultural, and cognitive biases through which one normally filters their ...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
- Rejuvenation— A renewed sense of physical vitality, mental freshness, and emotional restoration that can emerge du...
- Thought connectivity— A state in which disparate thoughts, concepts, and ideas become fluidly and spontaneously interconne...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Auditory(4)
- Auditory distortion— Auditory distortion is the experience of sounds becoming warped, pitch-shifted, flanged, or otherwis...
- Auditory enhancement— Auditory enhancement is a heightened sensitivity and appreciation of sound in which music, voices, a...
- Auditory hallucination— Auditory hallucination is the perception of sounds that have no external source — hearing music, voi...
- Auditory misinterpretation— Auditory misinterpretation is the brief, spontaneous misidentification of real sounds as entirely di...
Multi-sensory(4)
- Machinescapes— Machinescapes are complex multisensory hallucinations involving the perception of enormous mechanica...
- Olfactory hallucination— Olfactory hallucinations (phantosmia) involve the perception of convincing phantom smells — pleasant...
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
- Synaesthesia— Stimulation of one sense triggers involuntary experiences in another — seeing sounds as colors, tast...
Transpersonal(4)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Spirituality enhancement— A profound intensification of spiritual feelings, mystical awareness, and a sense of sacred connecti...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
4-HO-MiPT is a partial agonist at serotonin 5-HT2A receptors, the molecular switch responsible for classical psychedelic effects across the tryptamine family. The methyl-isopropyl substitution pattern on the terminal nitrogen creates a molecule of intermediate steric bulk -- larger than psilocin's dimethyl but smaller than the diisopropyl compounds that tend toward reduced potency. This particular geometry appears to hit a sweet spot: potent enough for full psychedelic effects at 15-25 mg, but with a character that leans toward sensory enhancement rather than ego dissolution.
What distinguishes 4-HO-MiPT pharmacologically from psilocin is likely its receptor selectivity profile at non-5-HT2A targets. The isopropyl group changes how the molecule sits in serotonin receptor binding pockets, and the unusually strong tactile and somatic effects suggest meaningful 5-HT2C and possibly 5-HT1A activity beyond what psilocin produces. The anxiolytic warmth that users consistently describe -- a honey-like calm that sets in before the visuals arrive -- is characteristic of compounds with significant 5-HT1A partial agonism.
The 4-Hydroxy Advantage
4-HO-MiPT is a free phenol, meaning the hydroxyl group at the 4-position is already exposed and active. Unlike 4-AcO prodrugs that require esterase metabolism to liberate the active phenol, miprocin works as-is. This translates to a cleaner, more predictable onset curve: the molecule does not need your liver to activate it, so variation in first-pass metabolism matters less.
Harmala Potentiation
Community documentation of 4-HO-MiPT combined with harmine, harmaline, and tetrahydroharmine (MAO inhibitors from Syrian rue, Peganum harmala) reveals a pharmacologically significant interaction. MAO inhibition blocks the primary degradation pathway for tryptamines, dramatically reducing clearance. A 4-6 hour experience becomes 8-12 hours, intensity increases roughly 2-3 fold, and the dose required drops by 50-70%. This is not a casual combination -- it transforms the experience into something closer to ayahuasca in duration and depth.
Pharmacokinetics
Oral onset occurs within 20-45 minutes, faster than most 4-HO tryptamines. Peak effects are reached at 1.5-2.5 hours. Total duration is 4-6 hours, with an afterglow of 2-4 hours. The isopropyl group likely confers modest metabolic stability compared to psilocin's dimethyl, as MAO-A has slightly less affinity for the asymmetric alkyl chain. No formal human pharmacokinetic studies exist. Rapid tolerance develops within 24-48 hours; full cross-tolerance with psilocybin, LSD, and other 5-HT2A agonists.
Detection Methods
Urine Detection
4-HO-MiPT is not targeted by standard immunoassay-based urine drug screens. Specialized LC-MS/MS methods can detect 4-substituted tryptamine metabolites in urine for approximately 24 to 48 hours after ingestion. The detection window is relatively short compared to many other drug classes due to the rapid hepatic metabolism and renal clearance of tryptamine compounds. Psilocin (4-HO-DMT) is the most commonly targeted analyte in specialized tryptamine panels, and structural analogs may or may not be captured depending on the specific method.
Blood and Serum Detection
Blood detection windows for 4-HO-MiPT are short, typically 4 to 12 hours after oral ingestion. Peak plasma concentrations of the active metabolite occur within 1 to 2 hours. The rapid first-pass metabolism means that parent compound concentrations in blood are often negligible for 4-AcO prodrugs, while 4-HO compounds themselves are measured directly. LC-MS/MS is required for reliable serum detection at the low concentrations involved.
Standard Drug Panel Inclusion
4-HO-MiPT is NOT included on standard 5-panel, 10-panel, or 12-panel drug screens. Tryptamines do not cross-react with immunoassay targets for any of the standard panel analytes (amphetamines, cannabinoids, cocaine metabolites, opiates, PCP, benzodiazepines, or barbiturates). Detection requires a specific request for tryptamine or novel psychoactive substance testing at a reference laboratory. Some extended forensic panels include psilocin, which may capture certain 4-substituted tryptamines, but this coverage is not guaranteed for all structural variants.
Confirmatory Methods
Confirmatory identification of 4-HO-MiPT relies on LC-MS/MS with reference standards specific to the compound or its expected metabolites. GC-MS can also be used following appropriate derivatization. Immunoassay-based methods for psilocybin and psilocin exist but show variable cross-reactivity with structural analogs and are not considered reliable for novel 4-substituted tryptamines. Reference laboratories specializing in novel psychoactive substances offer the most comprehensive detection capabilities.
Reagent Testing (Harm Reduction)
The Ehrlich reagent is the primary harm reduction tool for 4-HO-MiPT. A sample placed on the reagent should produce a purple to violet color change, confirming the presence of an indole ring system characteristic of tryptamines. This reaction is shared with LSD, psilocybin, DMT, and all indole-containing compounds, so it confirms the general class but not the specific identity. The Hofmann reagent provides a confirmatory blue to violet reaction for tryptamines. The Marquis reagent typically shows no reaction or a dark brown discoloration with 4-substituted tryptamines. A positive Ehrlich result significantly reduces the probability that the substance is a dangerous substitute such as an NBOMe compound.
Interactions
| Substance | Status | Note |
|---|---|---|
| 3-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-MMC | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 8-Chlorotheophylline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Adrafinil | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Anandamide | Caution | Cannabis can unpredictably intensify psychedelic effects and increase anxiety |
| Cannabis | Uncertain | — |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 25E-NBOH | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 2C-T-2 | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
Origins in Shulgin's Laboratory
4-HO-MiPT traces its lineage directly to Alexander Shulgin's systematic exploration of the tryptamine pharmacophore. Shulgin documented MiPT (N-methyl-N-isopropyltryptamine, the base tryptamine without the 4-hydroxy group) in TiHKAL: The Continuation (1997), cataloging its synthesis, subjective effects, and position in the structure-activity landscape. The 4-hydroxy variant was a logical next step, following the established pattern that 4-hydroxylation of simple tryptamines reliably converts them into full psychedelics -- the same modification that turns DMT into psilocin.
Research Chemical Market (2000s-2010s)
Miprocin appeared in the online research chemical market in the early 2000s, part of a broader wave of synthetic 4-HO tryptamines that included 4-HO-MET, 4-HO-DET, 4-AcO-DMT, and others. It was initially overshadowed by 4-AcO-DMT (which marketed itself as a psilocybin analog) but gradually built a dedicated following among users who discovered its distinctive sensory profile. By the 2010s, miprocin had developed a reputation in online psychedelic communities as something genuinely different from its siblings -- not just another psilocin analog, but a compound with its own character.
Community Recognition and Niche Status
Among the synthetic 4-HO tryptamines, miprocin occupies a specific niche: the body tryptamine, the tactile one, the one people recommend for sensory exploration and music. Reddit discussions from the mid-2010s onward document a community taking the compound seriously, with detailed reports comparing it to other members of the family, documenting harmala combination protocols, and sharing harm reduction knowledge. It has never achieved the mainstream recognition of 4-AcO-DMT or the notoriety of 5-MeO-DMT, but within the research chemical psychedelic community, miprocin is a respected name.
Legal Status
4-HO-MiPT is not specifically scheduled in most jurisdictions as of 2026. In the United States, it falls under the Federal Analogue Act as a structural analog of psilocin, making it potentially illegal for human consumption. It is explicitly banned in some countries including the United Kingdom (under the Psychoactive Substances Act 2016) and Sweden. The legal landscape varies significantly by jurisdiction and is subject to change.
Harm Reduction
Test Before You Trust
Ehrlich reagent is the baseline: miprocin should turn purple to violet, confirming the indole tryptamine structure. Given the research chemical market's track record of mislabeled products, reagent testing is non-negotiable. A milligram-accurate scale (±0.001g) is equally essential -- the difference between a gentle experience and a difficult one can be 5 mg.
Dosing
- Threshold: 5 mg |Light: 5-10 mg |Common: 12-25 mg |Strong: 25-35 mg
- Start at 10-12 mg for a first experience. The body load increases significantly above 25 mg
- Insufflation is reported at 40-50 mg in community posts but is harsher, faster, and harder to control. Oral is strongly recommended
- Do not redose during the come-up. Effects build for 45-60 minutes. Premature redosing is the most common path to an uncomfortably intense experience
The Body Load Is Real
Miprocin produces more physical discomfort than most 4-HO tryptamines. Nausea during onset is common, muscle tension can be significant, and vasoconstriction may cause cold extremities or an unpleasant "buzzing" sensation. Ginger tea before dosing helps with nausea. Magnesium glycinate (200-400 mg) taken an hour beforehand can reduce muscle tension. Staying warm and hydrated addresses the vasoconstriction.
MAOI and Harmala Combinations
This is where miprocin can become genuinely dangerous if mishandled. Combining with harmalas transforms the experience: duration doubles or triples, intensity increases dramatically, and the dose must be cut by 50-70%. If you are going to explore this combination, have extensive experience with both substances separately, have a knowledgeable sober sitter present, plan for an 8-12 hour commitment, and have a benzodiazepine available as emergency rescue medication. Serotonin syndrome is a real risk at high doses with MAOI potentiation.
Set and Setting
Miprocin rewards intentional preparation. Its introspective clarity and emotional depth respond strongly to environment: music selected in advance, a comfortable and private space, people you trust deeply. This is not a party compound. Its tactile enhancement makes physical comfort -- soft surfaces, warm lighting, temperature control -- unusually important.
When It Gets Difficult
Benzodiazepines (diazepam 10-20 mg, alprazolam 0.5-1 mg) reliably reduce intensity and are the standard rescue medication for overwhelming tryptamine experiences. Change the physical environment if possible -- a different room, going outside, changing the music. Physical grounding works well with miprocin specifically because the body awareness is so heightened: cold water on wrists, a weighted blanket, slow breathing.
Toxicity & Safety
Acute Physical Toxicity
No formal human toxicological studies of 4-HO-MiPT exist. Safety assessment relies on class membership (4-hydroxy tryptamines as a group have extremely favorable acute toxicity profiles) and accumulated community experience over roughly two decades of use without documented fatalities attributable to the compound's pharmacological action alone. The therapeutic index for classical psychedelics is generally very wide, and there is no reason to believe miprocin deviates from this pattern.
Physiological Effects at Standard Doses
Mild sympathomimetic stimulation: pupil dilation, heart rate elevation of 10-20 bpm, mild blood pressure increase. The isopropyl group appears to contribute a more pronounced body load compared to psilocin, including muscle tension, jaw clenching, vasoconstriction (cold hands and feet), and gastrointestinal discomfort. These effects are dose-dependent and generally peak during the first 90 minutes.
Nausea and Gastrointestinal Distress
Onset nausea is common and occasionally forceful, though it typically resolves within 30-45 minutes. At higher doses (above 25 mg), gastrointestinal discomfort can persist into the peak. Fasting for 2-3 hours before dosing and using ginger preparations can reduce this significantly.
MAOI Combination: Elevated Risk Profile
Combining 4-HO-MiPT with harmalas or pharmaceutical MAOIs introduces substantially elevated risk:
- Serotonin syndrome -- MAO inhibitors combined with potent serotonin agonists can produce a life-threatening condition characterized by hyperthermia, muscle rigidity, agitation, and autonomic instability
- Dose miscalculation -- A dose that is manageable alone becomes dangerously intense with MAOI potentiation; mandatory 50-70% dose reduction
- Extended duration -- A 4-6 hour experience becomes 8-12 hours, increasing cumulative psychological and physical strain
- Unpredictable intensity ceiling -- The potentiation is not linear; small increases in tryptamine dose produce disproportionate increases in effect
Psychological Risks
- Challenging experiences -- Higher doses produce intensely introspective states that can surface difficult psychological material. The body-awareness amplification means physical anxiety symptoms (racing heart, muscle tension) are also amplified, which can feed psychological distress
- Psychosis risk -- Standard absolute contraindication for individuals with personal or family history of schizophrenia, schizoaffective disorder, or bipolar I disorder
- HPPD -- Possible, as with all 5-HT2A agonist psychedelics. Risk likely increases with higher doses and more frequent use
Drug Interactions
- MAOIs (harmalas, pharmaceutical) -- Serious potentiation and serotonin syndrome risk; requires expertise and major dose reduction
- Lithium -- Absolute contraindication; documented seizure risk with serotonergic psychedelics
- Cannabis -- Unpredictable intensity amplification; can convert a manageable experience into an overwhelming one
- SSRIs/SNRIs -- Reduced effects likely; serotonin syndrome theoretically possible but rare at standard doses
Addiction Potential
4-HO-MiPT is not addictive by any conventional measure. It produces no physical dependence, no withdrawal syndrome, and no compulsive drug-seeking behavior. Rapid tolerance develops within 24-48 hours of a single dose, making daily use pharmacologically pointless -- a second dose the next day would produce dramatically reduced effects. Full cross-tolerance exists with psilocybin, LSD, mescaline, and all other 5-HT2A agonist psychedelics, which naturally prevents substitution patterns. Tolerance resets to baseline within approximately 7-14 days. Among all drug classes, classical psychedelics consistently rank at the very bottom for addiction potential. A small number of users may develop a pattern of using miprocin as psychological escape or repeatedly pursuing peak experiences, but this is uncommon and categorically different from the escalating, compulsive use that defines substance use disorders. The intensity of the experience itself, including the body load and the emotional depth, tends to be self-limiting -- most users space their sessions weeks to months apart.
Overdose Information
Can You Fatally Overdose on 4-HO-MiPT?
Fatal overdose from miprocin's pharmacological action alone is extremely unlikely based on the safety profile of classical tryptamine psychedelics. No deaths attributable to 4-HO-MiPT toxicity have been documented. The therapeutic index for 4-hydroxy tryptamines is very wide.
Recognizing a Crisis
The real danger is psychological, not physical. Watch for:
- Severe panic and anxiety that does not respond to reassurance or environmental changes
- Loss of contact with reality -- the person cannot recognize where they are or who they are with
- Dangerous behavior resulting from impaired reality testing
- Self-harm ideation or attempts during a distressing experience
- Signs of serotonin syndrome (particularly relevant if MAOIs are involved): muscle rigidity, rapidly rising body temperature, agitation, tremor, diarrhea, rapid heart rate
What to Do
For psychological distress: move the person to a calm, quiet, dimly lit environment. Speak in a low, steady voice. Provide simple, concrete reassurance: "You took a substance. You are safe. This will end." Physical grounding is especially effective with miprocin because body awareness is heightened -- a hand on the shoulder, a cool cloth on the forehead, a weighted blanket. Benzodiazepines (diazepam 10-20 mg or alprazolam 0.5-1 mg) reliably reduce intensity if the person can swallow.
For medical emergencies: call emergency services immediately if you observe seizures, dangerously elevated body temperature, signs of serotonin syndrome, loss of consciousness, or any suggestion of self-harm. Good Samaritan laws protect people seeking help during drug emergencies in many jurisdictions. There is no specific antidote; emergency treatment is supportive.
Tolerance
| Full | almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
Brazil: As of August 21, 2018, 4-HO-MiPT has been added to Portaria SVS/MS nº 344. Possession, distribution and use of this substance is now considered illegal.
Germany: 4-HO-MiPT is controlled under the NpSG (New Psychoactive Substances Act) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable. The legislator considers it possible that orders of 4-HO-MiPT are punishable as an incitement to place it on the market.
Japan: 4-HO-MiPT is a controlled substance in Japan effective March 25th, 2015.
Poland: 4-HO-MiPT is a NPS class drug in Poland, making it illegal to possess or distribute.
Sweden: 4-HO-MiPT is classified as a health hazard under the act Lagen om förbud mot vissa hälsofarliga varor (translated as the "Act on the Prohibition of Certain Goods Dangerous to Health") as of November 1, 2005, making it illegal to sell or possess.
Switzerland: 4-HO-MiPT is a controlled substance specifically named under Verzeichnis E.
United Kingdom: 4-HO-MiPT is a Class A drug in the United Kingdom as a result of the tryptamine catch-all clause.
United States: 4-HO-MiPT is unscheduled in the United States. It may be considered an analogue of psilocin (4-HO-DMT) which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.
Responsible use
Psychedelics
Tryptamines
Psilocin (4-HO-DMT)
4-HO-MiPT (Wikipedia)
4-HO-MiPT (Erowid Vault)
4-HO-MiPT (TiHKAL / Isomer Design)
Discussion
4-HO-MiPT (Bluelight)
Experience Reports (4)
Tips (8)
Do not combine 4-HO-MiPT with lithium (seizure risk), tramadol (seizure/serotonin syndrome risk), or cannabis at higher doses unless very experienced. Cannabis dramatically intensifies and can destabilize a psychedelic experience.
Combining 4-HO-MiPT with harmalas (Syrian rue, harmine) drastically intensifies and extends the experience. Reduce your 4-HO-MiPT dose by at least 50-70% if adding harmalas, and be prepared for a much longer trip (8-12+ hours).
4-HO-MiPT is often described as having a darker, more 'gothic' visual aesthetic compared to 4-HO-MET. The imagery tends toward organic, ornate, and sometimes eerie patterns. This is not necessarily unpleasant but worth knowing if you prefer lighter psychedelics.
Have a trip sitter present, ideally someone with psychedelic experience. They should remain calm and reassuring without being intrusive. A good sitter can make the difference between a challenging experience and a genuine crisis.
4-HO-MiPT can work as a first psychedelic experience at low doses (10-15mg), but its body load is heavier than 4-HO-MET with more nausea and temperature fluctuations. Have ginger tea and blankets ready. 4-HO-MET is generally recommended as the gentler introduction.
Using 4-HO-MiPT in celebratory social settings (15-20mg) is enjoyable for experienced users. The empathogenic undertone makes it good for bonding, though the headspace is deeper than typical party psychedelics. Best for small gatherings with close friends.
Community Discussions (5)
See Also
Same Class
References (4)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- 4-HO-MiPT - TripSit Factsheet
TripSit factsheet for 4-HO-MiPT
tripsit - 4-HO-MiPT - Wikipedia
Wikipedia article on 4-HO-MiPT
wikipedia